financetom
Market
financetom
/
Market
/
Piramal Enterprises to buy back shares worth Rs 1,750 crore at Rs 1,250 apiece after 12 years
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Piramal Enterprises to buy back shares worth Rs 1,750 crore at Rs 1,250 apiece after 12 years
Jul 28, 2023 6:49 AM

Diversified group Piramal Enterprises Ltd (PEL) on Friday announced a share buyback scheme worth Rs 1,750 crore at Rs 1,250 apiece via tender route.

Share Market Live

NSE

"...we wish to inform you that the board of directors of the company at its meeting held on July 28, 2023, approved a buyback by the company of up to 1,40,00,000 equity shares of the company of face value of Rs 2/- each for an aggregate amount not exceeding Rs 1,750 crore," Piramal Enterprises said in a regulatory filing.

The offer represents a premium of 16.5 percent to the July 28 (Friday) closing price of Rs 1,072.80.

The company plans to buy back 5.87 percent of the total shares and the company's promoter and promoter group have expressed their intention not to participate in the buyback, it said.

Also Read: Cipla promoters in talks to sell part stake to private equity firms, say sources

The board has fixed Friday, August 25, 2023, as the record date for the purpose of determining the entitlement and names of the shareholders eligible to participate in the buyback.

A share buyback is when a company repurchases its own shares from existing shareholders to reduce the number of shares available on the open market.

The second buyback scheme from Piramal Enterprises comes after 12 years. The first buyback of Rs 2,508 crore was between January 17-February 7, 2011.

Also Read: L&T becomes the second non-IT firm to announce Rs 10,000 crore buyback

Shares of Piramal Enterprises Ltd ended at Rs 1,072.80, down by Rs 23.55, or 2.15 percent on the BSE.

(Edited by : Pradeep John)

First Published:Jul 28, 2023 3:49 PM IST

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Top Midday Decliners
Top Midday Decliners
Sep 5, 2025
02:10 PM EDT, 09/05/2025 (MT Newswires) -- Youxin Technology ( YAAS ) said Friday it has priced an underwritten public offering of about 21.4 million units at $0.28 each to raise about $6 million. Shares sank 64% following an increase in intraday trading volume to over 81.1 million from a daily average of about 2.33 million. Lululemon Athletica ( LULU...
Top Midday Gainers
Top Midday Gainers
Sep 5, 2025
01:46 PM EDT, 09/05/2025 (MT Newswires) -- SINTX Technologies ( SINT ) said Wednesday it published a peer-reviewed study demonstrating that silicon nitride exhibits potent antiviral activity against multiple infectious virus strains, including SARS-CoV-2 and MERS-CoV. Shares surged about 36% as intraday trading volume soared to nearly 1.6 million from a daily average of roughly 746,000. Gelteq ( GELS )...
Update: Gold Rises As Dollar and Yields Plunge After a Report Showed U.S. Hiring Stalled in July
Update: Gold Rises As Dollar and Yields Plunge After a Report Showed U.S. Hiring Stalled in July
Sep 5, 2025
02:00 PM EDT, 09/05/2025 (MT Newswires) -- Gold traded higher midafternoon on Friday, rising as the dollar and yields moved sharply lower after U.S. hiring stalled in July, firming expectations the Federal Reserve will move to lower interest rates beginning this month. Gold for December delivery was last seen up US$44.10 to US$3,650.80 per ounce. Following reports Thursday showing higher...
Sector Update: Health Care Stocks Rise Friday Afternoon
Sector Update: Health Care Stocks Rise Friday Afternoon
Sep 5, 2025
01:46 PM EDT, 09/05/2025 (MT Newswires) -- Health care stocks advanced Friday afternoon, with the NYSE Health Care Index up 0.2% and the Health Care Select Sector SPDR Fund (XLV) adding 0.2%. The iShares Biotechnology ETF (IBB) climbed 1.5%. In corporate news, United Therapeutics ( UTHR ) has a clear path for additional revenue of $5.4 billion from Tyvaso by...
Copyright 2023-2026 - www.financetom.com All Rights Reserved